Drug factory · FDA FEI 1000613242
Huzhou Zhanwang Pharmaceutical Co., Ltd.
West Development Area Rd, Linghu Town, Huzhou, China
No problems found at FDA's last inspection, Mar 29, 2024.
No Action Indicated: inspectors found no objectionable conditions.
4 drug inspections on record since 2010: 2 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Milrinone | Makes the active ingredient | Fresenius Kabi, LLC | 63323-617 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 29, 2024 | No problems found | Drug Quality Assurance | — |
| Apr 8, 2016 | No problems found | Drug Quality Assurance | — |
| Sep 13, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 16, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.